NO984162D0 - 5,11-dihydrobenzo(b,e)(1,4)oksazepinderivater og farmasöytiske sammensetninger inneholdende de samme - Google Patents
5,11-dihydrobenzo(b,e)(1,4)oksazepinderivater og farmasöytiske sammensetninger inneholdende de sammeInfo
- Publication number
- NO984162D0 NO984162D0 NO984162A NO984162A NO984162D0 NO 984162 D0 NO984162 D0 NO 984162D0 NO 984162 A NO984162 A NO 984162A NO 984162 A NO984162 A NO 984162A NO 984162 D0 NO984162 D0 NO 984162D0
- Authority
- NO
- Norway
- Prior art keywords
- compositions containing
- dihydrobenzo
- same
- pharmaceutical compositions
- eüä1
- Prior art date
Links
- WXLCDTBTIVJDCE-UHFFFAOYSA-N 1,4-oxazepine Chemical class O1C=CC=NC=C1 WXLCDTBTIVJDCE-UHFFFAOYSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 230000000694 effects Effects 0.000 abstract 2
- 230000002411 adverse Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract 1
- 150000004677 hydrates Chemical class 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000007659 motor function Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP8310496 | 1996-03-11 | ||
| PCT/JP1997/000754 WO1997033885A1 (en) | 1996-03-11 | 1997-03-11 | 5,11-DIHYDRODIBENZ[b,e][1,4]OXAZEPINE DERIVATIVES AND DRUG COMPOSITIONS CONTAING THE DERIVATIVES |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO984162D0 true NO984162D0 (no) | 1998-09-10 |
| NO984162L NO984162L (no) | 1998-11-05 |
| NO310976B1 NO310976B1 (no) | 2001-09-24 |
Family
ID=13792896
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO19984162A NO310976B1 (no) | 1996-03-11 | 1998-09-10 | 5,11-dihydrobenzo[b,e][1,4]oksazepinderivater og farmasoytiske sammensetninger inneholdende de samme |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US6127361A (no) |
| EP (1) | EP0889043B1 (no) |
| JP (1) | JP3127469B2 (no) |
| KR (1) | KR100344331B1 (no) |
| CN (1) | CN1085209C (no) |
| AT (1) | ATE204871T1 (no) |
| AU (1) | AU704521B2 (no) |
| BR (1) | BR9707962A (no) |
| CA (1) | CA2261271C (no) |
| DE (1) | DE69706406T2 (no) |
| ES (1) | ES2159843T3 (no) |
| NO (1) | NO310976B1 (no) |
| PT (1) | PT889043E (no) |
| TW (1) | TW479057B (no) |
| WO (1) | WO1997033885A1 (no) |
| ZA (1) | ZA972038B (no) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2304262A1 (en) | 1997-09-10 | 1999-03-18 | Ajinomoto Co., Inc. | 5,11-dihydrodibenzo[b,e][i,4]oxazepine derivatives and pharmaceutical composition containing the same |
| EP1475373A1 (en) * | 1999-01-08 | 2004-11-10 | Ajinomoto Co., Inc. | 5,11-Dihydrodibenzo[b,e][1,4]-oxazepine derivatives as calcium channel antagonists |
| EP1219611A4 (en) * | 1999-09-03 | 2003-03-19 | Ajinomoto Kk | NEW PROCESSES FOR THE PRODUCTION OF OXAZEPINE DERIVATIVES |
| WO2002048120A1 (en) * | 2000-12-11 | 2002-06-20 | Ajinomoto Co.,Inc. | Novel crystals of oxazepine derivatives and process for the production thereof |
| WO2002096891A1 (en) * | 2001-05-30 | 2002-12-05 | Ajinomoto Co.,Inc. | Dihydrodiaryloxazepine derivative and medicinal composition containing the derivative |
| JP2005343791A (ja) * | 2002-05-31 | 2005-12-15 | Ajinomoto Co Inc | 消化管疾患を治療するための医薬組成物 |
| JP2005343790A (ja) * | 2002-05-31 | 2005-12-15 | Ajinomoto Co Inc | カルシウムチャネル拮抗薬を含有する医薬組成物 |
| CN104016937B (zh) * | 2014-05-09 | 2016-12-07 | 中科院广州化学有限公司 | 一种n-芳基氧氮杂卓酮类化合物及其制备方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8912303D0 (en) * | 1989-05-27 | 1989-07-12 | Pfizer Ltd | Therapeutic agents |
| EP0613472A1 (en) * | 1991-11-05 | 1994-09-07 | G.D. Searle & Co. | 10-acyl-dibenz(b,f) (1,4)-oxazepines and their thiazepines analo gues useful as prostaglandin antagonists |
| US20020183271A1 (en) * | 2000-12-07 | 2002-12-05 | Sunil Chada | Methods of treatment involving human MDA-7 |
-
1997
- 1997-03-10 TW TW086102931A patent/TW479057B/zh not_active IP Right Cessation
- 1997-03-10 ZA ZA9702038A patent/ZA972038B/xx unknown
- 1997-03-11 BR BR9707962A patent/BR9707962A/pt not_active IP Right Cessation
- 1997-03-11 CN CN97193005A patent/CN1085209C/zh not_active Expired - Fee Related
- 1997-03-11 KR KR1019980707117A patent/KR100344331B1/ko not_active Expired - Fee Related
- 1997-03-11 DE DE69706406T patent/DE69706406T2/de not_active Expired - Fee Related
- 1997-03-11 PT PT97905478T patent/PT889043E/pt unknown
- 1997-03-11 ES ES97905478T patent/ES2159843T3/es not_active Expired - Lifetime
- 1997-03-11 JP JP09532434A patent/JP3127469B2/ja not_active Expired - Fee Related
- 1997-03-11 US US09/147,012 patent/US6127361A/en not_active Expired - Fee Related
- 1997-03-11 WO PCT/JP1997/000754 patent/WO1997033885A1/ja not_active Ceased
- 1997-03-11 AT AT97905478T patent/ATE204871T1/de not_active IP Right Cessation
- 1997-03-11 AU AU22335/97A patent/AU704521B2/en not_active Ceased
- 1997-03-11 EP EP97905478A patent/EP0889043B1/en not_active Expired - Lifetime
- 1997-03-11 CA CA002261271A patent/CA2261271C/en not_active Expired - Fee Related
-
1998
- 1998-09-10 NO NO19984162A patent/NO310976B1/no unknown
-
2000
- 2000-06-19 US US09/597,409 patent/US6436922B1/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| KR100344331B1 (ko) | 2002-12-05 |
| AU704521B2 (en) | 1999-04-22 |
| NO310976B1 (no) | 2001-09-24 |
| JP3127469B2 (ja) | 2001-01-22 |
| BR9707962A (pt) | 1999-07-27 |
| CA2261271C (en) | 2003-09-16 |
| US6127361A (en) | 2000-10-03 |
| KR19990087655A (ko) | 1999-12-27 |
| WO1997033885A1 (en) | 1997-09-18 |
| AU2233597A (en) | 1997-10-01 |
| NO984162L (no) | 1998-11-05 |
| ZA972038B (en) | 1997-09-17 |
| CN1213371A (zh) | 1999-04-07 |
| TW479057B (en) | 2002-03-11 |
| DE69706406D1 (de) | 2001-10-04 |
| CN1085209C (zh) | 2002-05-22 |
| EP0889043B1 (en) | 2001-08-29 |
| EP0889043A4 (en) | 1999-07-21 |
| DE69706406T2 (de) | 2002-04-18 |
| ES2159843T3 (es) | 2001-10-16 |
| ATE204871T1 (de) | 2001-09-15 |
| CA2261271A1 (en) | 1997-09-18 |
| PT889043E (pt) | 2002-02-28 |
| EP0889043A1 (en) | 1999-01-07 |
| US6436922B1 (en) | 2002-08-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR1100987A (pt) | Composto, composição farmacêutica da matéria, e, composição veterinária | |
| RU95108759A (ru) | Фармацевтические соединения | |
| DZ2494A1 (fr) | Composition pharmaceutique d'oméprazole. | |
| CY2543B1 (en) | 9-Ä(Substituted glycyl)amidoÜ-6-(substituted)-5-hydroxy-6-deoxytetracyclines | |
| IL136285A0 (en) | Pharmaceutical compositions containing an acid-labile active component | |
| ITRM990338A0 (it) | Composizione dietetica o farmaceutica utile per la prevenzione o il trattamento dell'iperossaluria. | |
| WO1997030677A3 (en) | Pentafluorobenzenesulfonamides and analogs | |
| RU94035686A (ru) | 4-ариламино-бензопиран и родственные соединения, фармацевтическая композиция, способ лечения | |
| TR199801268T2 (xx) | Ta�ikinin antagonistleri olarak 3-Azetidinilalkilpiperidinler veya pirolidinler. | |
| TR200001906T2 (tr) | Koks-Inhibitörleri olarak 2,3-ikameli indol bileşikleri. | |
| EA199900621A1 (ru) | Лечение рассеянного склероза путем приема внутрь или ингаляции сополимера-1 | |
| EP0807633A3 (en) | Novel 2,3-disubstituted-(5,6)- heteroarylfused-pyrimidine-4-ones | |
| DE69631609D1 (en) | Tricyclische erythromycinderivate | |
| NO306116B1 (no) | Ny benzotiadiazinforbindelse og farmasöytiske sammensetninger | |
| ES2151698T3 (es) | Nuevos derivados de 6-hidroxi y 6-oxo-androstan activos sobre el sistema cardiovascular y composiciones farmaceuticas que los contienen. | |
| NO984162D0 (no) | 5,11-dihydrobenzo(b,e)(1,4)oksazepinderivater og farmasöytiske sammensetninger inneholdende de samme | |
| EA200000996A1 (ru) | Конденсированные с арилом азаполициклические соединения | |
| FI960658A0 (fi) | Uudet bis-naftalimidit syövän hoitamiseksi | |
| RU94040150A (ru) | Стабильная лиофилизированная композиция тиотепа, способ ее получения | |
| EP1073447A4 (en) | N1-MODIFIED GLYCOPEPTIDES | |
| RU95107655A (ru) | Глюкопиранозидбензотиофены, способ получения, фармацевтическая композиция | |
| KR970061248A (ko) | 알츠하이머병 치료용 1, 1, 2-트리페닐부트-1-엔 유도체 | |
| MX9709453A (es) | Composicion farmaceutica oral de compuestos de piperidinoalcanol en forma de solucion. | |
| TW330933B (en) | Furanoeremophilane and eremophilanolide sesquiterpenes for treatment of diabetes | |
| ES2184121T3 (es) | Formulacion para el tratamiento y/o profilaxis de la demencia. |